Literature DB >> 19631389

Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells.

Tamara Tilburgs1, Sicco A Scherjon, Barbara J van der Mast, Geert W Haasnoot, Minke Versteeg-V D Voort-Maarschalk, Dave L Roelen, Johannes J van Rood, Frans H J Claas.   

Abstract

Human leukocyte antigen-C (HLA-C) is the only polymorphic classical histocompatibility antigen expressed by fetal trophoblasts at the fetal-maternal interface. Interactions between HLA-C and decidual natural killer (NK) cells may facilitate trophoblast invasion into maternal tissue. Thus far no evidence has been provided that decidual T cells specifically recognize and respond to fetal alloantigens at the fetal-maternal interface. In this study, we show that pregnancies containing a HLA-C mismatched child induce an increased percentage of CD4(+)CD25(dim) activated T cells in decidual tissue. In addition, HLA-C mismatched pregnancies exhibit a decidual lymphocyte response to fetal cells and contain functional CD4(+)CD25(bright) regulatory T cells in decidual tissue, whereas HLA-C matched pregnancies do not. This suggests that decidual T cells specifically recognize fetal HLA-C at the fetal-maternal interface but are prevented from inducing a destructive immune response in uncomplicated pregnancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631389     DOI: 10.1016/j.jri.2009.05.003

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  72 in total

1.  Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2011-09-27       Impact factor: 3.886

2.  Origin of Foxp3(+) cells during pregnancy.

Authors:  Ana Teles; Catharina Thuere; Paul Ojiambo Wafula; Tarek El-Mousleh; Maria Laura Zenclussen; Ana Claudia Zenclussen
Journal:  Am J Clin Exp Immunol       Date:  2013-10-16

3.  Human labour is associated with altered regulatory T cell function and maternal immune activation.

Authors:  N M Shah; L F Edey; N Imami; M R Johnson
Journal:  Clin Exp Immunol       Date:  2019-11-03       Impact factor: 4.330

Review 4.  T cell behavior at the maternal-fetal interface.

Authors:  Patrice Nancy; Adrian Erlebacher
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 5.  CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.

Authors:  Tamara Tilburgs; Jack L Strominger
Journal:  Am J Reprod Immunol       Date:  2013-02-23       Impact factor: 3.886

Review 6.  Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications.

Authors:  R Díaz-Peña; M J de Los Santos; Alejandro Lucia; P Castro-Santos
Journal:  J Assist Reprod Genet       Date:  2019-03-07       Impact factor: 3.412

Review 7.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

Review 8.  Mechanisms of T cell tolerance towards the allogeneic fetus.

Authors:  Adrian Erlebacher
Journal:  Nat Rev Immunol       Date:  2012-12-14       Impact factor: 53.106

9.  Fetal intervention increases maternal T cell awareness of the foreign conceptus and can lead to immune-mediated fetal demise.

Authors:  Marta Wegorzewska; Amar Nijagal; Charissa M Wong; Tom Le; Ninnia Lescano; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2014-01-10       Impact factor: 5.422

Review 10.  Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections.

Authors:  Ângela C Crespo; Anita van der Zwan; João Ramalho-Santos; Jack L Strominger; Tamara Tilburgs
Journal:  J Reprod Immunol       Date:  2016-08-02       Impact factor: 4.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.